טוען...
The proliferation and invasion of osteosarcoma are inhibited by miR-101 via targetting ZEB2
Having a better grasp of the molecular mechanisms underlying carcinogenesis and progression in osteosarcoma would be helpful to find novel therapeutic targets. Different types of cancers have presented abnormal expression of miRNA-101 (miR-101). Nevertheless, we still could not figure out what expre...
שמור ב:
| הוצא לאור ב: | Biosci Rep |
|---|---|
| Main Authors: | , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Portland Press Ltd.
2019
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6367128/ https://ncbi.nlm.nih.gov/pubmed/30692230 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1042/BSR20181283 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|